ABEC stainless steel fermenters will enhance New England Biolabs’ biotechnology research capabilities Bethlehem, PA, USA – ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced it is delivering multiple 40L stainless steel fermenters to New England Biolabs® (NEB®), further supporting their high-density fermentation of recombinant Escherichia coli and Pichia pastoris. NEB has again selected ABEC based [...]

WOBURN, Mass. -- Curiox Biosystems, Inc., a global leader in biological sample preparation for life science research, today announced that it has named Don O'Neil to the newly created position of Chief Commercialization Officer (CCO). The position will be responsible for all commercial efforts and will collaborate with Curiox's established management team to develop and advance awareness and [...]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired NanoView Biosciences today. NanoView’s ExoView technology sits in pole position for characterizing exosomes and their recently launched LentiView platform is a game-changer for gene therapy researchers working with lentivirus. Exosomes are messenger [...]

FARNBOROUGH, England, and BUDAPEST, Hungary -- Mediso Ltd today announced the acquisition of Bartec Technologies Ltd, UK based company specialised in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories. The acquisition strengthens Mediso's market position in the UK and Ireland. Financial details of the acquisition were not disclosed. Mediso Medical Imaging Systems with [...]

Paradigm4 has today unveiled REVEALTM: Proteomics, the newest use case specific app powered by the Paradigm4 FLASHTM high-performance bioinformatics platform. REVEAL: Proteomics unlocks the power of advanced mass spec proteomics by simplifying cross sample and cross study searching for protein isoforms as potential biomarkers for drug response or disease progression. REVEAL: Proteomics directly addresses the [...]

Evanston, IL –  The global professional services firm ZS announced today that it has acquired Danish bioinformatics and systems biology company, Intomics. Founded in Copenhagen, Denmark in 2008, Intomics accelerates and optimizes pharmaceutical drug discovery and development by enabling complex analysis of biomedical data. The addition of renowned scientists to the ZS team will strengthen ZS’s [...]

BARDA’s Division of Research, Innovation, and Ventures (DRIVe) is collaborating with multiple industry and academic partners to advance the ability to quickly respond to public health emergencies with a new diagnostic capability that covers all existing and new respiratory RNA viruses in a single test. Most of today’s clinical diagnostic tools are designed to detect [...]

Allelica and Invitae aim to decrease the gap in polygenic risk score (PRS) performance in individuals from diverse genetic ancestries, ensuring that the life-saving integration of genomic information into breast cancer risk assessments can benefit all women NEW YORK -- Allelica has formalized a partnership with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to build a [...]

Cambridge, United Kingdom – Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, announces the appointment of Dr. Tom Barber as Chief Scientific Officer. Dr. Barber will lead the development and delivery of Congenica’s scientific and clinical vision to become the global leader in genome annotation [...]

Funding round includes investments from Purdue Foundry and Elevate Ventures WEST LAFAYETTE, Ind. – Novilytic LLC, a biochemistry analytics company that protects and secures lifesaving drugs, has completed a $1.6 million seed round in addition to its $1.4 million National Institutes of Health Small Business Innovation Research grant. The seed round investments include contributions from [...]